secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001437749-25-010729
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Talphera raises $4.9M in first closing of private placement; additional closings contingent on trial enrollment
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.9M from first closing: 3,405,118 shares and pre-funded warrants for 4,999,316 shares at $0.586/share.
- Second closing of ~$4.9M triggered by enrollment of ≥17 patients in Niyad NEPHRO CRRT study and VWAP ≥$0.7325.
- Third closing of ~$4.9M triggered by enrollment of ≥35 patients in same study and VWAP ≥$0.7325.
- Pre-funded warrants have $0.001 exercise price, unlimited term, and are exercisable immediately at each closing.
- Registration rights agreement filed; executive officers and directors subject to 90-day lock-up after effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774925010729/0001437749-25-010729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774925010729/acrx20250401_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-010729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer